Gang Han, PhD, said newly developed nano-optogenetic immunotherapy represents a new generation of personalized cancer treatment, in which precise control of the timing, location and dosage of T-cell activation could be tailored to an individual patient.

The UMass Cancer Center Pilot Project Program has awarded seed grants to five UMass Chan Medical School research projects to enable investigators to gather pilot data for external cancer-focused funding.

Research by Sharon Cantor, PhD, into how chemotherapy works in inherited breast and ovarian cancer overturned a long-held model in the field and will play a key role in developing successful therapies.

The 23rd annual UMass Cancer Walk and Run, held on Sunday, Oct. 17, at Polar Park in Worcester, is expected to bring in more than $700,000, exceeding fundraising goals.

In its most diverse class to date, the National Academy of Medicine has elected Job Dekker, PhD, and Katherine Fitzgerald, PhD, for their distinguished contributions to medicine and health.

The 23rd annual UMass Cancer Walk and Run will be held Sunday, Oct. 17, at Polar Park in Worcester. More than 2,300 participants have registered for the event. Gates open at 9:30 a.m.